September 5, 2023

Zenas BioPharma Announces Strategic License and Collaboration Agreement with Bristol Myers Squibb to Develop and Commercialize Novel Bi-Functional Antibody Obexelimab in Japan, South Korea, Taiwan, Singapore, Hong Kong and Australia

Collaboration furthers Zenas’ vision to bring innovative immunology-based medicines to patients around the world by leveraging Bristol Myers Squibb’s long-standing expertise in immune-mediated diseases Zenas will receive a $50 million

Reading More

IMF Says No to Lowering Electricity Bills

The International Monetary Fund (IMF) has outright rejected Pakistan’s request for relief in inflated electricity rates for aggrieved citizens.Following the federal government’s assertion that electricity bill collection for August

Reading More

RECENT NEWS

Search Keywords

Search